作为抗炎剂的胺衍生物:在体中向COX-2和在PGE的 Vitro抑制2生产2生产
Héctor M Heras Martínez1,2, Blanca Sánchez-Ramírez1, Linda-Lucila Landeros-Martínez1
1Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Chihuahua 31125, Mexico.
Pharmaceutics
|January 28, 2026
概括
研究人员开发了新型N-phthalimide杂交物作为选择性循环氧化酶-2 (COX-2) 抑制剂. 6,10和17的化合物显示出对前列腺素E2 (PGE2) 的强烈抑制,以及对抗炎药物开发有前途的安全性概况.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环氧化酶-2 (COX-2) 抑制剂对公共卫生至关重要,但开发选择性剂仍然是一个挑战.
- 聚胺混合物为设计新型治疗剂提供了一个有前途的支架.
- 了解结构-活性关系是优化COX-2抑制的关键.
研究的目的:
- 设计,合成和评估新型N-phthalimide杂交物作为选择性COX-2抑制剂.
- 研究这些化合物的 in silico 和 in vitro 疗效和安全性.
- 确定用于开发更安全的抗炎药物的主要候选药物.
主要方法:
- 计算方法包括DFT几何优化和对抗COX-2和COX-1酶的分子对接.
- 在LPS刺激的巨细胞中合成和体外评估N-phthalimide杂交物.
- 对前列腺素E2 (PGE2) 抑制,细胞活力和细胞毒性的评估.
主要成果:
- 最好的候选物 (化合物6,10和17) 显示出对COX-2比COX-1的预测选择性.
- 试验室研究证实了对PGE2生产的强烈抑制,其中化合物10和17显示>95%的疗效.
- 所有测试的化合物都表现出有利的ADMET配置文件,并保持高细胞活力,表明细胞毒性低.
结论:
- 用天然和合成碎片混合胺基架的战略杂交产生了强大的PGE2抑制剂.
- 化合物6,10和17被确定为开发更安全的抗炎药物的有希望的主要候选物.
- 综合的in silico-in vitro方法在识别潜在的候选药物方面被证明是有效的.
更多相关视频
相关概念视频
00:46Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
02:27Predicting Products: SN1 vs. SN2
17.3K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
17.3K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
538
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
538
01:19The Mantel-Cox Log-Rank Test
1.0K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.0K
01:28Inflammatory Response
16.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.6K
01:35Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
2.6K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.6K